Investors Heavily Search e.l.f. Beauty (ELF): Here is What You Need to Know

e.l.f. Beauty shares have plunged ~45% over the past month amid heavy investor attention and large downward revisions to earnings estimates — the Zacks consensus for current-quarter EPS has fallen ~45.7% in 30 days and fiscal-year estimates have been cut materially, driving a Zacks Rank of #5 (Strong Sell). Analysts still project revenue growth (consensus +27% YoY for the current quarter and ~19% for the year), but the company missed revenue estimates in the last reported quarter ($343.9m vs. $366.5m consensus) even as EPS surprised positively; Zacks flags e.l.f. as expensive relative to peers (Value Style Score F). The combination of sharp estimate downgrades, recent top-line miss and a premium valuation suggests the stock is vulnerable to further downside despite healthy revenue growth prospects.

Analysis

Shares of e.l.f. Beauty plunged 45.3% over the past month, materially underperforming the Zacks S&P 500 composite (-2.8%) and the Zacks Cosmetics industry (-20.6%), reflecting sharp negative investor sentiment and repositioning. Sell-side estimate revisions have been extreme: the Zacks consensus for current-quarter EPS is $0.72 (–2.7% YoY) but has declined 45.7% in the last 30 days, full-year EPS of $2.93 is down 13.6% with a 31.3% 30-day cut, and next-year EPS is projected at $3.73 (+27.3% YoY) yet the 30-day revision is –15.6%; Zacks has moved the stock to Rank #5 (Strong Sell) on these dynamics.

Top-line dynamics are mixed: consensus sales for the current quarter are $452.79m (+27.4% YoY) and fiscal-year sales are projected up ~19%, but the most recent quarter showed revenue of $343.94m (+14.2% YoY) that missed the $366.53m consensus (–6.16%) even as EPS beat by 19.3% and the company has topped EPS three of the last four quarters. Valuation flags compound the risk profile: e.l.f. carries a Zacks Value Style Score of F, indicating it trades at a premium to peers despite the downgrade cycle.

The convergence of steep estimate cuts, a recent top-line miss, sustained revenue growth expectations, and premium relative valuation implies the stock is vulnerable to further downside unless estimates stabilize or management delivers clearer margin/revenue inflection in upcoming results.

Key Decisions for Investors

• Reduce or avoid initiating new long positions until consensus EPS revisions stop declining and the Zacks Rank improves from #5,
• Monitor the next quarterly report and guidance closely for revenue/margin confirmation versus the consensus $452.8m quarterly sales and any reversal in the recent estimate cuts,
• If maintaining exposure, implement downside protection such as hedges or put options given the elevated downside risk from valuation (Zacks Value Score F) and recent volatility,
• Consider re-evaluating position size only after multiple consecutive beats or material positive revisions to FY EPS from the current $2.93 estimate